Rosie’s 1990s boom-bust comics article at IGN. In Hive Mind (28:20), X-Ray is thrilled to welcome Sarah Kuhn and Arielle Jovellanos, writer and artist behind DC’s “Girl Taking Over: A Lois Lane Story.” And in Nerd Out (1:01:46) a listener pitches Nimona. In the Airlock (7:32) Jason and Rosie dive deep (deeep) into Adult Swim’s My Adventures with Superman.
#XRAY VISION PODCAST PLUS#
On this episode of X-Ray Vision, Jason Concepcion and Rosie Knight rom-com with Clark Kent and Lois Lane! In Previously On (1:37), they discuss a new superhero movie-making satire ordered by struck company HBO plus renewed speculation about a Disney sale to Apple. The Entertainment Community Fund’s Support Staff Donation page. The Listener’s Guide to all things X-Ray Vision!Ĭonsider donating to the Entertainment Community Fund here.
#XRAY VISION PODCAST FREE#
Send a short pitch and 2-3 minute voice memo recording to that answers the following questions: 1) How did you get into/discover your ‘Nerd Out?’ (2) Why should we get into it too? (3) What’s coming soon in this world that we can look forward to or where can we find it? If you’re sending a theory, feel free to send only a summary of your theory (no audio needed) for Jason and Rosie to react to on air.įollow Rosie: IG, Letterboxd, & newsletter Tune in every Wednesday & Friday and don’t forget to Hulk Smash the Follow button! Thank you for your patience as we work to resolve this issue. Note: Imprecise timestamps are an unfortunate side effect of a new ads system. Then in Nerd Out (55:45) friend of the pod, and co-host of Escape Hatch (formerly Dune Pod), Haitch pitches Warrior. The same for adjusted earnings per share is pinned at $12., indicating an improvement of 3% from the previous year’s recorded number.On this episode of X-Ray Vision, Jason Concepcion and Rosie Knight open the mailbag! In the Airlock (1:10) Jason and Rosie dive deep (deeep) into your questions, including what fandom they want to explore, consuming content during the strikes, superpower reveals, how watching affects mood, Saw Patrol, and more. The Zacks Consensus Estimate for the company's fiscal 2023 revenues is pegged at $3.55 billion, implying growth of 7.3% from the 2022 reported figure. Contraction in both gross and operating margins is disappointing. Moreover, an increase in selling, general and administrative expenses is concerning. Fluctuations in foreign exchange rates may significantly hamper its overseas revenues. The Cooper Companies generates a significant portion of its revenues in foreign currencies. The deal should accelerate the commercialization of novel spectacle lens technologies and expand the myopia management category. In 2022, the company formed a joint venture, SightGlass Vision, with another global vision care leader, EssilorLuxottica. The deal should have boosted bottom-line by nearly 30 cents in 2022, a trend that is likely to have continued in 2023. The new business significantly boosted sales for the Office and surgical, and Fertility segments in the first half of 2023. In 2021, The Cooper Companies acquired privately held Generate Life Sciences, a leading provider of donor eggs and sperms for fertility treatments, fertility cryopreservation services and newborn stem cell storage (cord blood & cord tissue). It also experienced an organic improvement in sales on a geographical basis, with EMEA, the Americas and the Asia-Pacific markets exhibiting strength in the aforementioned quarter. In the fiscal second quarter of 2023, the company witnessed substantial growth across CVI’s Toric, Multifocal and single-use sphere subunits. Its flagship silicone hydrogel lenses are expected to derive strong sales in the upcoming quarters. What's Driving the Company's Performance?ĬOO has been leading the specialty lenses market, owing to highly exclusive products of Biofinity and Clariti, and growing products of MyDay and MiSight. Its earnings beat estimates in two of the trailing four quarters and missed the mark in the other two, delivering an average surprise of 0.01%. The company’s bottom line is estimated to improve 10% over the next five years. The Cooper Companies, with a market capitalization of $19.25 billion, is a specialty medical device company operating on a global basis.
0 kommentar(er)
